Physician profile
Anna Gale
NPI 1215603949
$1,251.29
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,052 · 2023: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $199.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $263.77 | 2022-2023 | |
| Novo Nordisk INC | $203.08 | 2022-2023 | Wegovy |
| Lilly USA, LLC | $197.12 | 2022-2023 | Mounjaro |
| Glaxosmithkline, LLC. | $84.13 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $75.50 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $75.47 | 2022-2023 | Trintellix |
| Dexcom, INC. | $58.67 | 2022 | |
| Amgen INC. | $54.84 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $49.88 | 2022-2023 | Fasenra, Farxiga |
| Irhythm Technologies, INC. | $48.79 | 2022-2023 | Zio Xt Patch |
| Almatica Pharma LLC | $43.00 | 2022 | |
| Amarin Pharma, INC. | $23.82 | 2022 | |
| Exact Sciences Corporation | $21.99 | 2023 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.92 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.13 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $15.18 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Gale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.